Journey Medical Corporation announced that the Company has entered into a credit facility with an affiliate of SWK Holdings Corporation, a specialized finance company with a focus on the global healthcare sector, providing for borrowings of up to $20...
Read Story
January 03, 2024, 07:33 AM
|
SWK Holdings, a life-science-focused, specialty finance company catering to small- and mid-sized commercial-stage companies, announced an amendment to its revolving credit facility. The amended credit facility provides total commitments of $60...
Read Story
October 12, 2023, 07:36 AM
|
SWK Holdings Corporation, a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, signed a new four-year credit facility with First Horizon Bank. The four-year facility, which has $45 million...
Read Story
June 30, 2023, 08:02 AM
|
SWK Holdings Corporation, a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, announced the signing of the 5th Amendment to the Loan and Security Agreement with Cadence Bank. The amendment...
Read Story
November 17, 2022, 07:28 AM
|
SWK Holdings Corporation announced that the company has promoted Yvette Heinrichson to the role of Chief Financial Officer. Ms. Heinrichson was previously SWK's Chief Accounting Officer. SWK has also promoted John David ("J.D.") Tamas to Director of...
Read Story
October 05, 2022, 07:00 AM
|
Aziyo Biologics, a commercial-stage regenerative medicine company entered into a $25 million credit facility from SWK Holdings Corporation.The new credit facility provides for an initial term loan of $21 million that the Company intends to use to...
Read Story
August 11, 2022, 07:09 AM
|
Acerus Pharmaceuticals Corporation entered into an amended agreement related to its existing credit facility with SWK Funding LLC, a subsidiary of SWK Holdings Corporation.The nature of the amendments are to: i) set principal repayment at US$1.1...
Read Story
March 26, 2021, 07:57 AM
|
CeloNova BioSciences, Inc., a medical device company that develops, manufactures and markets a family of innovative cardiovascular products based upon its novel Polyzene™-F nanocoating technology, announced the completion of a 4-year joint financing...
Read Story
August 08, 2017, 07:08 AM
|